TBBCF Scientific Advisory Committee
Nicholas Saccomano, PhD, Chair
Chief Scientific Officer, Array BioPharma Inc.
John LaMattina, PhD, Co-Chair
Former President, Pfizer Global Research and Development
Michael Garabedian, PhD
Professor and Course Director, New York University Medical Center
Stacey Gualtieri, CPA
President, Doherty,Beals and Banks;
Grants Administrator for the Scientific Advisory Committee
Susan Logan, PhD
Associate Professor, New York University Medical Center
Mike Morin, PhD
President and CEO, Oncovia Therapeutics, Inc.
|
Past Grant Recipients
2007
Oliver, Andrea MD Dana-Farber Cancer Institute
Chatterjee, Samit PhD Cold Spring Harbor Laboratory
Mayer, Erica MD, MPH Dana-Farber Cancer Institute
Lee, Dongoo PhD Memorial Sloan Kettering
2008
Irie, Hanna Y MD, PhD Mount Sinai School of Medicine
Choudhury, Sibgat PhD Dana-Farber Cancer Institute
Fertuck, Kirsten PhD Dana-Farber Cancer Institute
2009
Bialucha, Carl Uli PhD Cold Spring Harbor Laboratory
Kutuk, Ozgur MD, PhD Dana-Farber Cancer Institute
Bailey, Shannon T. MD Dana-Farber Cancer Institute
Zang, Qing PhD Dana-Farber Cancer Institute Full Listing
|
|
|
|
|
| Norma Logan, co-founder of the Terri Brodeur Breast Cancer Foundation, believed passionately that every fundraising dollar to the Foundation should go directly to breast cancer research. It is with great pleasure and pride that we announce the TBBCF research grant recipients for 2015. |
Congratulations to the 2015 TBBCF Research Grant Recipients
Click here to read the project summaries and biographies for the 2015 grant recipients.
|
|
TBBCF Scientific Advisory Committee Announces 2015 Grant Recipients
|
|
Dear TBBCF Supporters,
 | | Dr. John LaMattina |
Everyone has been profoundly impacted in some way by breast cancer. Be it a friend, relative, partner or spouse, this disease causes much sorrow and loss. TBBCF is dedicated to supporting research to find a cure for breast cancer and, thanks to hundreds of walkers, volunteers and sponsors over the last nine years, over $3 million has been raised to facilitate such important new research.
Specifically, TBBCF seeks to fund young researchers in the Northeast who are carrying out groundbreaking science into the causes of breast cancer, its proliferation and methods to treat existing disease. More
|
Our Scientific Advisory Committee
 | | Dr. Nick Saccomano |
The idea of funding breast cancer research requires technical expertise to analyze and develop funding mechanisms, a fluency in the sciences, and especially, a vision of the future: and a gaze toward the novel therapies and people who might unravel the mysteries of breast cancer promoting therapies to combat the disease.
The founding Scientific Advisory Committee (SAC) volunteered to lead this mission while pursuing their own demanding careers as scientists, business leaders, and scientific researchers. In the past nine fundraising years, the SAC has awarded $3M in research dollars to fund new efforts to eradicate breast cancer.
In the process of granting these monies, they have reviewed over 200 formal proposals and interviewed numerous candidates. Their strategy is to continue to build name recognition in the area and build outward slowly. More
|
|
|
|
|
